LIANBio (NASDAQ:LIAN) Skyrockets 130% With Exclusive Cardiovascular Deal – $350 Million Payout!


Shares of LIANBio (NASDAQ:LIAN) are on an exhilarating ride today, surging an incredible 130% in the wake of a groundbreaking deal. This Chinese biotech firm, specializing in the development and commercialization of medicines for cardiovascular, oncology, ophthalmology, and inflammatory diseases in Asia, has just struck gold. In a major announcement, LIANBio has inked an exclusive … Read more